SCHEMBL30497449

SCHEMBL30497449

O=C1COCC1NC(=O)[C@@H]1CCCC[C@H]1C(=O)N1CCc2[nH]c3c(F)cccc3c2C1

nearest known ligand 0.51

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ CTSK P43235 16/20 0.51
▸ CTSB P07858 5/20 0.45
▸ CTSS P25774 1/20 0.45
▸ CFTR P13569 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30497443 0.94 CTSK (0.44) CTSKCTSBCTSS
SCHEMBL30497448 0.94 CTSK (0.44) CTSKCTSBCTSS
SCHEMBL29076231 0.94 CTSK (0.44) CTSKCTSBCTSS
SCHEMBL29076234 0.94 CTSK (0.44) CTSKCTSBCTSS
SCHEMBL30497445 0.88 CTSK (0.52) CTSKCTSBCTSS
SCHEMBL29076287 0.88 CTSK (0.52) CTSKCTSBCTSS
SCHEMBL29076290 0.88 CTSK (0.52) CTSKCTSBCTSS
SCHEMBL30497440 0.88 CTSK (0.65) CTSKCTSBCTSS
SCHEMBL29076298 0.87 CTSK (0.61) CTSKCTSBCTSS
SCHEMBL30497438 0.87 CTSK (0.61) CTSKCTSBCTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250145576-A1 CATHEPSIN K INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF SHANDONG NEW TIME PHARMACEUTICAL CO., LTD. (CN) 2025-05-08 — — US claimed
EP-4467544-A1 CATHEPSIN K INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF Shandong New Time Pharmaceutical Co., Ltd. (CN) 2024-11-27 — — EP claimed
CN-118742549-A Cathepsin K inhibitor, preparation method and application thereof 山东新时代药业有限公司 2024-10-01 — — CN claimed
CN-116514804-A Cathepsin K inhibitor, preparation method and application thereof 山东新时代药业有限公司 2023-08-01 — — CN claimed
WO-2023138695-A1 CATHEPSIN K INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF 山东新时代药业有限公司 2023-07-27 — — WO claimed
US-20250145576-A1 CATHEPSIN K INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF SHANDONG NEW TIME PHARMACEUTICAL CO., LTD. (CN) 2025-05-08 — — US disclosed
EP-4467544-A1 CATHEPSIN K INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF Shandong New Time Pharmaceutical Co., Ltd. (CN) 2024-11-27 — — EP disclosed
CN-118742549-A Cathepsin K inhibitor, preparation method and application thereof 山东新时代药业有限公司 2024-10-01 — — CN disclosed
CN-116514804-A Cathepsin K inhibitor, preparation method and application thereof 山东新时代药业有限公司 2023-08-01 — — CN disclosed
WO-2023138695-A1 CATHEPSIN K INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF 山东新时代药业有限公司 2023-07-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250145576-A1 CATHEPSIN K INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF CTSF, CTSK, CTSZ CTSK 2/4885CTSB 9/4885CTSS 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback